Recently, Leadingpharm Medical Technology Development Co., Ltd. and China Resources Life Technology (Beijing) Co., Ltd. signed a strategic agreement on project cooperation.

Leadingpharm (stock code: 600222) was established in 2005. It is a high-tech enterprise providing pharmacy pre-clinical research, clinical CRO and CDMO services to the whole world. It has been rated as "China’s Top 10 Pharmaceutical R&D Enterprises "for many years (ranked first in 2019). The company is headquartered in Beijing Zhongguancun High-tech Park and has established New Drug Screening and Testing Platform, Drug Evaluation Platform (animal room, certified by GLP, AAALAC, CNAS), Large Molecule Pilot and Large-scale Production Platform, Small Molecule CMC Research and Production Platform, Cell Technology Platform and Clinical CRO Platform in Lifezhengzhou. The six platforms comply with international standards (FDA, EMA and NMPAGMP) , forming Leadingpharm CXO Whole Industry Chain Service System. The combination of imitation and creation, driven by dual engines, can provide customers with diversified services throughout the pharmaceutical research and development.

China Resources Life Technology (Beijing) Co., Ltd. is a wholly-owned subsidiary of China Resources Life Science Group Co., Ltd. Based on the capital's advantages in innovative resources, China Resources life science group has built a "China Resources Life Science Park" in the biomedical base of Daxing District, Beijing. It has grasped the direction of international life science and technology, deployed the innovation chain and value chain around the industrial chain, strengthened the aggregation of innovation elements, actively used the cutting-edge scientific and technological achievements in biotechnology, life science and related fields to establish the service system and bearing platform, which adapt to the development of the industrial chain and the innovation chain. Create a healthy complex of Industry-University-Research-Application Collaboration Integration, and strive to become an in-depth insight, strategic investor and innovation leader of the industry.

China Resources Life Technology undertakes the industrial management and scientific innovation services of all parks of China Resources Life Science Group. Its core business focuses on the enabling services of scientific and technological innovation. It has established a perfect service system for innovation incubation, transformation of scientific and technological achievements and industrialization, and has the ability to open to the outside world and serve the industrial chain. it helps light asset management output by service output, management output, product output and mode output, aiming to establish a complete industrial ecology that can be extended and upgraded iteratively for the trusteeship carrier.

Based on the principle of "win-win cooperation, complementary advantages, mutual empowerment and common development", the two sides will give full play to their respective advantages in resources, R & D and management, establish a long-term cooperation mechanism, explore multi-level cooperation opportunities, realize high standard management and sound development of projects, accelerate the construction of big health science and technology industry, and help the achievement of the Healthy China Strategy.
 

-END-